A 71-year-old woman presented with intractable cardiac failure 10 years after receiving treatment for lymphoma.
Introduction
Ante-mortem diagnosis of secondary cardiac tumours is made only infrequently and for cardiac involvement to be the sole clinical feature of the disease is extremely rare. Pericardial infiltration is now recognized more frequently, but myocardial or endocardial involvement is usually an autopsy diagnosis. Carcinoma of the breast, carcinoma of the bronchus, malignant melanoma, lymphoma and leukaemia produce cardiac inifitration most commonly and this should be suspected if patients with any of these malignancies develop sudden onset of tachycardias, arrhythmias or congestive cardiac failure, particularly if the latter is resistant to treatment with digoxin and diuretics (Malaret and Aliaga, 1968) . A patient in whom late relapse of lymphoma manifested itself as cardiac failure is described.
Case report
A 7 1-year-old woman was admitted to hospital in October 1981 with a one-year history of general ill health, increasing shortness of breath, a dry cough, anorexia and weight loss of approximately 10 kg. Ten years previously she had had an excision biopsy of an enlarged lymph node in the left groin and the histology was interpreted as reticulum cell sarcoma. She had been treated with local radiotherapy and was subsequently well, with no evidence of recurrence.
On examination she looked unwell and had a temperature of 37 5°C. There was no palpable lymphadenopathy or hepatosplenomegaly. The pulse rate was 110/min, regular and the blood pressure was 130/80 mmHg. The jugular venous pressure was not elevated and no cardiac murmurs or added sounds were audible, although the apex beat was displaced slightly laterally. The remainder of the examination was unremarkable.
The haemoglobin was 10-8 g/dl with a MCV of 86 fl and the white cell count was 8 4 x 109/litre with a normal differential count. The erythrocyte sedimentation rate was 80 mm in the 1st hr. Urea and electrolytes, serum thyroxine, serum protein electrophoresis and liver function tests were all normal and blood and urine cultures were sterile. The chest roentgenogram showed a moderately enlarged heart and clear lung fields and an electrocardiogram showed a sinus tachycardia with very low voltage complexes and a normal axis. An initial diagnosis of idiopathic cardiomyopathy was made.
Two weeks after admission she developed signs of rapidly worsening biventricular failure. The pulse rate rose to 130/min and the blood pressure fell to 90/60 mmHg, with poor peripheral perfusion and oliguria. The liver enlarged to 4 cm below the costal margin and was non-pulsatile and non-tender. The central venous pressure, which was originally + 4*5 cm water rose rapidly to + 13 cm water and treatment with digoxin and frusemide produced little improvement. In view of her rapid deterioration and past history of lymphoma, she was treated with COP chemotherapy (cyclophosphamide 1 g i. (Fig. 1) . A second course of COP chemotherapy again produced prompt clinical improvement, but a month later signs of cardiac decompensation reappeared and the patient died.
Autopsy examination revealed a massively enlarged heart (weight 065 kg) in which the right atrium and right ventricle were extensively replaced with tumour. A tumour mass was protruding into the cavity of the right atrium. Tumour deposits were also present on the parietal pleura and retrosternally but none was found below the diaphragm.
The histological appearances were interpreted as those of follicular centre cell lymphoma, centroblastic, diffuse, (Kiel classification) (Gerard-Marchant et al., 1974) . Comparison of the sections with those obtained 10 years earlier showed identical appearances.
Discussion
Lymphoma is one of the commonest tumours to metastasize to the heart and Roberts, Glancy and DeVita (1968) in a series of 196 patients with lymphoma, found evidence of cardiac metastases at autopsy in 24%. Tumour deposits were observed on gross examination of the heart in slightly more than half of the cases; in the remainder lymphoma was detected only after study of histological sections. The incidence of dyspnoea, chest pain, effusions into body cavities, precordial murmurs, ventricular gallops, oedema and electrocardiographic disturbances was similar in patients with and without cardiac lymphoma and in only 10% of cases could clinical features of cardiac dysfunction during life be attributed to lymphomatous involvement of the heart.
Symptoms and signs resulting from cardiac infiltration are, of course, related to the layer of the heart involved. Pericardial infiltration is recognized most frequently and produces chest pain, pericardial effusions with or without tamponade, constrictive pericarditis and arrhythmias. Myocardial and endocardial deposits tend to be more occult but may produce dysrhythmias, including heart block, embolism or obstruction (Roberts et al., 1968) . Lymphoma in the right atrium causing tricuspid valve obstruction and right heart failure has been reported occasionally, but is rare (Olsen, Bach-Nielsen and Piper, 1962; Garfein, 1976 ). In the patient described, the diagnosis was made particularly difficult by the absence of detectable disease elsewhere and by the long disease-free interval. A striking response to chemotherapy supported the presumptive diagnosis and further evidence was provided by cross-sectional echocardiography. Angiography and endomyocardial biopsy are also useful diagnostic techniques, the latter being especially valuable in excluding atrial myxoma which demands surgical treatment (Johnson and Popple, 1980) . Diagnosis of cardiac metastases in patients with lymphoma is important because radiation therapy may produce useful palliation. In one series, over half of the patients so treated responded and some lived free of cardiac symptoms, for more than a year (Cham et al., 1975) . Terry and Kligerman (1970) reported 7 patients with cardiac involvement from lymphomas and leukaemias who were treated with radiotherapy. Two patients (both with Hodgkin's disease involving the pericardium) were alive and apparently disease-free at 2 years and 1 year, respectively, and 3 of the remaining 5 patients achieved excellent palliation. Response of cardiac lymphoma to chemotherapy has also been documented (Garfein, 1976; Conde et al., 1975) . This was clearly the case in our patient, and the mechanism was probably relief of tricuspid valve obstruction.
However, although the clinical response to chemotherapy was gratifyingly prompt and dramatic, the patient died 1 month after her second course of treatment. The outcome of this case is similiar to that of two previously reported patients with nonHodgkin's lymphoma involving the heart; both had short survivals despite well-documented initial responses to chemotherapy (Garfein, 1976; Conde et al., 1975 
